Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Bide Pharmatech Co Ltd banner
B

Bide Pharmatech Co Ltd
SSE:688073

Watchlist Manager
Bide Pharmatech Co Ltd
SSE:688073
Watchlist
Price: 52.3 CNY -4.91% Market Closed
Market Cap: ¥4.8B
Write Note Create Alert Ask AI

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
What is Dividend Safety Rate?
Previous Payment
-
Today
Next Payment
-
Today
Mar 4, 2026
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-

Dividend Yield
Bide Pharmatech Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Dividend Per Share
Bide Pharmatech Co Ltd

Over the past 5 years, dividends per share for Bide Pharmatech Co Ltd have decreased by 0%.
What is dividend per share?
Dividend Streak
Growth 3Y
Growth 5Y
Growth 10Y
Ex-Dividend Date Amount Period Declaration Date Record Date Payment Date
Load More

Payout Ratio
Bide Pharmatech Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Payout Statistics, Past 5 Years
Min
Max
Current Payout
Min Payout
Max Payout
Average Payout
Median Payout

Peers Comparison
Dividends

Company Safety Rate Dividend Yield Dividend Per Share Growth 5Y Growth 10Y Payout Ratio

Shareholder Yield

Current shareholder yield for Bide Pharmatech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
= Dividend Yield
+ Buyback Yield
+ Debt Paydown Yield
Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Bide Pharmatech Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Bide Pharmatech Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Bide Pharmatech Co Ltd

1Y 3Y 5Y 10Y 15Y 20Y
Annual Price Range
52.3
52w Low
37.81
52w High
80.38
Price Metrics
Average Annual Return 3.49%
Standard Deviation of Annual Returns 15.94%
Max Drawdown -73%
Shares Statistics
Market Capitalization 4.8B CNY
Shares Outstanding 90 880 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

Bide Pharmatech Co Ltd's latest stock split occurred on May 25, 2023

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Bide Pharmatech Co Ltd traded at 92.0286 per share. Afterward, the share price was about 87.53.

The adjusted shares began trading on May 25, 2023. This was the only stock split in Bide Pharmatech Co Ltd's history.

View Stock Splits
Pre-Split Price
90.4886 92.0286
Post-Split Price
87.53
Before
After
View Stock Splits

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 321,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett